Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.030
+0.004 (0.34%)
Sep 16, 2025, 4:00 PM EDT - Market closed
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.63 million as of September 16, 2025. Its market cap has increased by 20.62% in one year.
Market Cap
5.63M
Enterprise Value
2.14M
1-Year Change
20.62%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.63M, a decrease of -78.49%. That is a compound annual growth rate of -31.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 5.61M | -7.23% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
| Aug 16, 2021 | 26.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |